Latest News and Press Releases
Want to stay updated on the latest news?
-
World’s #1 Selling Contact Lens Brand ACUVUE®1 Brings Pioneering Innovation For Astigmatic Patients, Providing Visual Clarity And Comfort+2 The First^^ Toric Lens to have an Optimised Design...
-
Dublin, Aug. 18, 2025 (GLOBE NEWSWIRE) -- The "3D Printing Plastics Market by Type (Photopolymer, ABS, Polyamide, PLA, PETG), Form (Filament, Liquid, Powder), Application (Prototyping,...
-
The Estonian economy continues to grow slowly, with the latest forecasts estimating annual economic growth at 1.2%. The construction market is showing signs of stabilisation. Within the buildings...
-
Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "3D Printed Prosthetics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" has been added to ResearchAndMarkets.com's...
-
FORESIGHT VENTURES VCT PLCLEI: 213800R88MRC4Y3OIW8631 July 2025 CORRECTION - FINAL RESULTS FOR THE YEAR ENDED 31 MARCH 2025 The announcement of the Company’s Final Results, which was originally made...
-
THE GROUP IS ACCELERATING ITS DEVELOPMENT CRÉDIT AGRICOLE S.A. CRÉDIT AGRICOLE GROUP €m Q2 2025 Change Q2/Q2 Q2 2025 Change Q2/Q2 Revenues 7,006 ...
-
FORESIGHT VENTURES VCT PLCLEI: 213800R88MRC4Y3OIW8629 July 2025 Final results31 March 2025 Foresight Ventures VCT plc, managed by Foresight Group LLP, today announces the final results for the year...
-
2025 half-year results Operational performance in line with expectationsPositive cash flow in a context of falling market prices and rising investmentsNet financial debt reduced Performance...
-
Landmark approval is based on results from the Phase 3 AQUILA study, showing fixed-duration treatment with daratumumab significantly reduced the risk of progression to active multiple myeloma or death...
-
Ibrutinib is the first approved Bruton’s tyrosine kinase (BTK) inhibitor to demonstrate statistically meaningful outcomes versus autologous stem cell transplant (ASCT) for the frontline treatment of...